Ask Aeroz

Type the question you actually came here with.

DSCSA · EPCIS

EPCIS for DSCSA: the standard FDA recommends.

EPCIS for DSCSA is the use of GS1's Electronic Product Code Information Services standard to exchange DSCSA transaction information and transaction statements electronically, which FDA recommends in its September 2023 final guidance for the enhanced requirements in effect since 27 November 2023.

EPCIS is the GS1 standard FDA recommends for DSCSA data exchange. In its September 2023 final guidance, FDA tells manufacturers, repackagers, wholesale distributors and dispensers to use EPCIS to provide and maintain transaction information and transaction statements under the enhanced requirements of section 582(g)(1) of the FD&C Act, in effect since 27 November 2023.

GS1 EPCISFDA guidance Sept 2023Section 582(g)(1)27 Nov 2023Transaction information
Key facts · reviewed

EPCIS for DSCSA, in three facts.

FDA final guidance, September 2023 · DSCSA standards for the interoperable exchange of tracing information · GS1 EPCIS · enhanced requirements in effect 27 November 2023.

  • In its final guidance of September 2023 on DSCSA standards for the interoperable exchange of tracing information, FDA recommends that trading partners use GS1's Electronic Product Code Information Services (EPCIS) standard to provide and maintain the data associated with transaction information and transaction statements.

    Source: FDA, DSCSA Standards for the Interoperable Exchange of Information for Tracing (final guidance, September 2023)
  • Under DSCSA, transaction information is the product name, strength and dosage form, NDC, container size, number of containers, lot number, transaction date, shipment date if more than 24 hours later, and the business name and address of the seller and the buyer.

    Source: 21 U.S.C. §360eee(26) (Cornell LII)
  • Section 582(g)(1) of the FD&C Act put the DSCSA enhanced drug distribution security requirements, interoperable electronic tracing of product at the package level, into effect 10 years after 27 November 2013, that is on 27 November 2023.

    Source: 21 U.S.C. §360eee-1(g)(1) (Cornell LII)
What the rule requires

What FDA says, and what EPCIS carries.

FDA recommends EPCIS

FDA's final guidance on DSCSA standards for the interoperable exchange of information for tracing, dated September 2023, recommends that trading partners use the Electronic Product Code Information Services (EPCIS) standard to provide and maintain the data associated with transaction information and transaction statements. FDA calls EPCIS an appropriate globally recognized standard.

One standard, several technologies

FDA does not expect every trading partner to use the same technology. It recommends an approach that uses EPCIS, notes that email and web portals that use EPCIS could enable compliance, and says that for data capture and exchange a trading partner should use EPCIS.

What the data has to say

Under DSCSA, transaction information is the product name, strength and dosage form, NDC, container size, number of containers, lot number, transaction date, shipment date if more than 24 hours later, and the business name and address of the seller and the buyer. Under the enhanced requirements it travels electronically with the product identifier for each package.

The law's date

Section 582(g)(1) of the FD&C Act put interoperable, electronic tracing of product at the package level into effect on 27 November 2023. FDA's exemptions for manufacturers, repackagers, wholesale distributors and larger dispensers ended in 2025; small dispensers are exempt until 27 November 2027.

The current GS1 version

GS1 published EPCIS and the Core Business Vocabulary (CBV) 2.0 in June 2022, followed by the EPCIS and CBV Implementation Guideline 2.0 in March 2023. FDA's guidance names EPCIS as the standard without fixing a version, so agree the version with each trading partner.

The dates

The timeline, as it stands.

The FDA guidance is a recommendation, not a rule, but it is the agency's stated view on the standard for DSCSA interoperability. The tracing requirements themselves come from section 582 of the FD&C Act.

GS1 EPCIS and CBV 2.0 publishedJun 2022
FDA final standards guidanceSep 2023
Enhanced requirements in effect27 Nov 2023
Small dispenser exemption ends27 Nov 2027
What to do now

Three moves that de-risk the deadline.

01 · Step

Map your data to transaction information

Check that every shipment record carries the ten transaction information elements, the transaction statement and the product identifier for each package, so the EPCIS events you send are complete.

02 · Step

Agree the version and route with each partner

List each immediate trading partner, the EPCIS version and the route you use (direct connection, network or portal), and test a shipment end to end before relying on it.

03 · Step

Keep the records for six years

Store the EPCIS data you send and receive so you can answer FDA and trading partner requests, including suspect product investigations, for at least six years.

How Aeroz fits

One record, in the format partners expect.

Because the tracing rules are federal, one system serves every state you operate in. Aeroz ties each unit's physical identity to its transaction record, so the evidence a trading partner produces is the same wherever it operates.

FAQ

EPCIS for DSCSA, answered.

How does EPCIS work in DSCSA?

Trading partners record each shipment as EPCIS events that carry the DSCSA transaction information, the transaction statement and the product identifiers of the packages, and send them to the next owner electronically. FDA's September 2023 final guidance recommends EPCIS for providing and maintaining this data.

Is EPCIS required for DSCSA?

The law requires interoperable, electronic exchange of transaction information and statements from 27 November 2023. It does not name EPCIS, but FDA's final guidance recommends EPCIS and says that for data capture and exchange a trading partner should use it.

What data does an EPCIS file carry for DSCSA?

The transaction information: product name, strength and dosage form, NDC, container size, number of containers, lot number, transaction date, shipment date if more than 24 hours later, and the seller's and buyer's business names and addresses, together with the transaction statement and package-level product identifiers.

Which EPCIS version should we use for DSCSA?

FDA names the EPCIS standard without fixing a version. GS1 published EPCIS and CBV 2.0 in June 2022, so agree the version with each trading partner and test the exchange before you rely on it.

Readiness audit

Know exactly where you stand, in 14 days.

A fixed-fee Aeroz audit maps your products against EPCIS data exchange for the DSCSA enhanced drug distribution security requirements and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.

Fixed fee: Readiness Report $2,500, Readiness Audit $4,500 14-day written report No commitment to proceed